Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure

Branka Stancevic, Nira Varda-Bloom, Jin Cheng, John D. Fuller, Jimmy A. Rotolo, Mónica García-Barros, Regina Feldman, Shyam Rao, Ralph R. Weichselbaum, Dror Harats, Adriana Haimovitz-Friedman, Zvi Fuks, Michel Sadelain, Richard Kolesnick

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acute microvascular endothelial apoptosis initiated via acid sphingomyelinase (ASMase) translocation to the external plasma membrane. Ensuing microvascular damage regulates radiation lethality of tumor stem cell clonogens to effect tumor cure. Based on this biology, we engineered an ASMase-producing vector consisting of a modified pre-proendothelin-1 promoter, PPE1(3x), and a hypoxia-inducible dual-binding HIF-2α-Ets-1 enhancer element upstream of the asmase gene, inserted into a replication-deficient adenovirus yielding the vector Ad5H2E-PPE1(3x)-ASMase. This vector confers ASMase over-expression in cycling angiogenic endothelium in vitro and within tumors in vivo, with no detectable enhancement in endothelium of normal tissues that exhibit a minute fraction of cycling cells or in non-endothelial tumor or normal tissue cells. Intravenous pretreatment with Ad5H2E-PPE1(3x)-ASMase markedly increases SDRT cure of inherently radiosensitive MCA/129 fibrosarcomas, and converts radiation-incurable B16 melanomas into biopsy-proven tumor cures. In contrast, Ad5H2E-PPE1(3x)-ASMase treatment did not impact radiation damage to small intestinal crypts as non-dividing small intestinal microvessels did not overexpress ASMase and were not radiosensitized. We posit that combination of genetic up-regulation of tumor microvascular ASMase and SDRT provides therapeutic options for currently radiation-incurable human tumors.

Original languageEnglish (US)
Article numbere69025
JournalPLoS One
Volume8
Issue number8
DOIs
StatePublished - Aug 7 2013
Externally publishedYes

Fingerprint

Sphingomyelin Phosphodiesterase
endothelium
Endothelium
Tumors
radiotherapy
neoplasms
Acids
acids
Radiotherapy
Dosimetry
Neoplasms
Radiation
dosage
Radiation damage
intestinal crypts
enhancer elements
Tissue
fibrosarcoma
Experimental Melanomas
Adenoviridae

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Stancevic, B., Varda-Bloom, N., Cheng, J., Fuller, J. D., Rotolo, J. A., García-Barros, M., ... Kolesnick, R. (2013). Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure. PLoS One, 8(8), [e69025]. https://doi.org/10.1371/journal.pone.0069025

Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure. / Stancevic, Branka; Varda-Bloom, Nira; Cheng, Jin; Fuller, John D.; Rotolo, Jimmy A.; García-Barros, Mónica; Feldman, Regina; Rao, Shyam; Weichselbaum, Ralph R.; Harats, Dror; Haimovitz-Friedman, Adriana; Fuks, Zvi; Sadelain, Michel; Kolesnick, Richard.

In: PLoS One, Vol. 8, No. 8, e69025, 07.08.2013.

Research output: Contribution to journalArticle

Stancevic, B, Varda-Bloom, N, Cheng, J, Fuller, JD, Rotolo, JA, García-Barros, M, Feldman, R, Rao, S, Weichselbaum, RR, Harats, D, Haimovitz-Friedman, A, Fuks, Z, Sadelain, M & Kolesnick, R 2013, 'Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure', PLoS One, vol. 8, no. 8, e69025. https://doi.org/10.1371/journal.pone.0069025
Stancevic B, Varda-Bloom N, Cheng J, Fuller JD, Rotolo JA, García-Barros M et al. Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure. PLoS One. 2013 Aug 7;8(8). e69025. https://doi.org/10.1371/journal.pone.0069025
Stancevic, Branka ; Varda-Bloom, Nira ; Cheng, Jin ; Fuller, John D. ; Rotolo, Jimmy A. ; García-Barros, Mónica ; Feldman, Regina ; Rao, Shyam ; Weichselbaum, Ralph R. ; Harats, Dror ; Haimovitz-Friedman, Adriana ; Fuks, Zvi ; Sadelain, Michel ; Kolesnick, Richard. / Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure. In: PLoS One. 2013 ; Vol. 8, No. 8.
@article{325d50dd24424c4b9dd242624fd1b64e,
title = "Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure",
abstract = "These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acute microvascular endothelial apoptosis initiated via acid sphingomyelinase (ASMase) translocation to the external plasma membrane. Ensuing microvascular damage regulates radiation lethality of tumor stem cell clonogens to effect tumor cure. Based on this biology, we engineered an ASMase-producing vector consisting of a modified pre-proendothelin-1 promoter, PPE1(3x), and a hypoxia-inducible dual-binding HIF-2α-Ets-1 enhancer element upstream of the asmase gene, inserted into a replication-deficient adenovirus yielding the vector Ad5H2E-PPE1(3x)-ASMase. This vector confers ASMase over-expression in cycling angiogenic endothelium in vitro and within tumors in vivo, with no detectable enhancement in endothelium of normal tissues that exhibit a minute fraction of cycling cells or in non-endothelial tumor or normal tissue cells. Intravenous pretreatment with Ad5H2E-PPE1(3x)-ASMase markedly increases SDRT cure of inherently radiosensitive MCA/129 fibrosarcomas, and converts radiation-incurable B16 melanomas into biopsy-proven tumor cures. In contrast, Ad5H2E-PPE1(3x)-ASMase treatment did not impact radiation damage to small intestinal crypts as non-dividing small intestinal microvessels did not overexpress ASMase and were not radiosensitized. We posit that combination of genetic up-regulation of tumor microvascular ASMase and SDRT provides therapeutic options for currently radiation-incurable human tumors.",
author = "Branka Stancevic and Nira Varda-Bloom and Jin Cheng and Fuller, {John D.} and Rotolo, {Jimmy A.} and M{\'o}nica Garc{\'i}a-Barros and Regina Feldman and Shyam Rao and Weichselbaum, {Ralph R.} and Dror Harats and Adriana Haimovitz-Friedman and Zvi Fuks and Michel Sadelain and Richard Kolesnick",
year = "2013",
month = "8",
day = "7",
doi = "10.1371/journal.pone.0069025",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure

AU - Stancevic, Branka

AU - Varda-Bloom, Nira

AU - Cheng, Jin

AU - Fuller, John D.

AU - Rotolo, Jimmy A.

AU - García-Barros, Mónica

AU - Feldman, Regina

AU - Rao, Shyam

AU - Weichselbaum, Ralph R.

AU - Harats, Dror

AU - Haimovitz-Friedman, Adriana

AU - Fuks, Zvi

AU - Sadelain, Michel

AU - Kolesnick, Richard

PY - 2013/8/7

Y1 - 2013/8/7

N2 - These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acute microvascular endothelial apoptosis initiated via acid sphingomyelinase (ASMase) translocation to the external plasma membrane. Ensuing microvascular damage regulates radiation lethality of tumor stem cell clonogens to effect tumor cure. Based on this biology, we engineered an ASMase-producing vector consisting of a modified pre-proendothelin-1 promoter, PPE1(3x), and a hypoxia-inducible dual-binding HIF-2α-Ets-1 enhancer element upstream of the asmase gene, inserted into a replication-deficient adenovirus yielding the vector Ad5H2E-PPE1(3x)-ASMase. This vector confers ASMase over-expression in cycling angiogenic endothelium in vitro and within tumors in vivo, with no detectable enhancement in endothelium of normal tissues that exhibit a minute fraction of cycling cells or in non-endothelial tumor or normal tissue cells. Intravenous pretreatment with Ad5H2E-PPE1(3x)-ASMase markedly increases SDRT cure of inherently radiosensitive MCA/129 fibrosarcomas, and converts radiation-incurable B16 melanomas into biopsy-proven tumor cures. In contrast, Ad5H2E-PPE1(3x)-ASMase treatment did not impact radiation damage to small intestinal crypts as non-dividing small intestinal microvessels did not overexpress ASMase and were not radiosensitized. We posit that combination of genetic up-regulation of tumor microvascular ASMase and SDRT provides therapeutic options for currently radiation-incurable human tumors.

AB - These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acute microvascular endothelial apoptosis initiated via acid sphingomyelinase (ASMase) translocation to the external plasma membrane. Ensuing microvascular damage regulates radiation lethality of tumor stem cell clonogens to effect tumor cure. Based on this biology, we engineered an ASMase-producing vector consisting of a modified pre-proendothelin-1 promoter, PPE1(3x), and a hypoxia-inducible dual-binding HIF-2α-Ets-1 enhancer element upstream of the asmase gene, inserted into a replication-deficient adenovirus yielding the vector Ad5H2E-PPE1(3x)-ASMase. This vector confers ASMase over-expression in cycling angiogenic endothelium in vitro and within tumors in vivo, with no detectable enhancement in endothelium of normal tissues that exhibit a minute fraction of cycling cells or in non-endothelial tumor or normal tissue cells. Intravenous pretreatment with Ad5H2E-PPE1(3x)-ASMase markedly increases SDRT cure of inherently radiosensitive MCA/129 fibrosarcomas, and converts radiation-incurable B16 melanomas into biopsy-proven tumor cures. In contrast, Ad5H2E-PPE1(3x)-ASMase treatment did not impact radiation damage to small intestinal crypts as non-dividing small intestinal microvessels did not overexpress ASMase and were not radiosensitized. We posit that combination of genetic up-regulation of tumor microvascular ASMase and SDRT provides therapeutic options for currently radiation-incurable human tumors.

UR - http://www.scopus.com/inward/record.url?scp=84880983166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880983166&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0069025

DO - 10.1371/journal.pone.0069025

M3 - Article

C2 - 23936314

AN - SCOPUS:84880983166

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e69025

ER -